Skip Ribbon Commands
Skip to main content
Manage PermissionsManage Permissions
Export Event


AstraZeneca: What Science Can Do


Mitchell Chan, Director of Investor Relations, AstraZeneca, North America​

Start Time

3/16/2016 5:00 PM

End Time

3/16/2016 9:00 PM

Global Passport Eligible?



Member Price


Non-Member Price


Candidate Price


Location Info

Boca Country Club
17751 Boca Club Blvd
Boca Raton, FL 33487​

Event Description


AztraZeneca: What Science Can Do

Please join us Wednesday, March 16 for filet mignon dinner and a presentation by Mitchell Chan of AstraZeneca, North America.

5:00pm Networking
6:00pm Dinner


Dinner: Filet Mignon (alternative available upon prior request).

Includes Dinner & One Free Drink
Free to Members & NonMembers/Guests!


AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit:

About AstraZeneca in Oncology

AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With at least 6 new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advance New Oncology as one of AstraZeneca’s six Growth Platforms focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy, as illustrated by our investment in Acerta Pharma in haematology.

By harnessing the power of four scientific platforms -- immuno-oncology, the genetic drivers of cancer and resistance, DNA damage repair and antibody drug conjugates -- and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.

Mitchell Chan

Director of Investor Relations, AstraZeneca, North America​

Mitchell Chan i​s responsible for managing AstraZeneca’s Investor Relations in North America. In this capacity he is responsible for Oncology and North American operations. Before AstraZeneca, Mitchell worked at Genentech/Roche, where he held roles in Mergers & Acquisitions, Commercial Finance, and Global Product Development Finance. He graduated with a BSc in Biochemistry, an MSc in Molecular Biophysics, and an MBA from the University of Toronto.


Society Category


Education Topic


Event Region


CE Credit


SER Credit


Event Terms

On-site registrations are accepted on an exception basis and are payable with check or credit card only. To cancel, please send an email to​ with your name, email address and CFA SFL member ID if applicable. ​

Advance registrations that fail to attend or that fail to cancel prior to 48 hours before the event will be billed at the non-member walk-in rate quoted for the event. If the event is subsidized for both members and non-members, late cancellations and no-shows may be billed at the actual cost per attendee. Cancellations for a full refund must be made at least 48 hours before an event. Registrations cancelled within the last 48 hours prior to an event are not eligible for a refund.

Location Name

Boca Country Club

All Day Event





3/16/2016 9:00 PM



Event Manager Email

Location Address

17751 Boca Club Blvd

Location City

Boca Raton, FL 33487

Event Link


Event Link Leads To New Tab


Event Short Info


Event Type

Approval Status Approved


CFA Society South Florida AstraZeneca and Strategic Value Investing.pdf    
Content Type: MyCFA Calendar
Created at 3/3/2016 11:38 PM by Ursula Auger
Last modified at 5/18/2016 9:54 PM by Ursula Auger